United States Gonadotropin Releasing Hormone Market Report 2016

November 2016 | 99 pages | ID: U616BA55EA8EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Gonadotropin Releasing Hormone

Revenue, means the sales value of Gonadotropin Releasing Hormone

This report studies sales (consumption) of Gonadotropin Releasing Hormone in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• AEterna Zentaris, Inc. (Canada)
• AstraZeneca Plc. (UK)
• Bayer HealthCare Pharmaceuticals, Inc. (USA)
• Eli Lilly and Company (USA)
• Meditrina Pharmaceuticals, Inc. (US)
• Neurocrine Biosciences, Inc. (US)
• Abbott Laboratories (USA)
• Repros Therapeutics, Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Gonadotropin Releasing Hormone in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Gonadotropin Releasing Hormone Market Report 2016

1 GONADOTROPIN RELEASING HORMONE OVERVIEW

1.1 Product Overview and Scope of Gonadotropin Releasing Hormone
1.2 Classification of Gonadotropin Releasing Hormone
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Gonadotropin Releasing Hormone
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Gonadotropin Releasing Hormone (2011-2021)
  1.4.1 United States Gonadotropin Releasing Hormone Sales and Growth Rate (2011-2021)
  1.4.2 United States Gonadotropin Releasing Hormone Revenue and Growth Rate (2011-2021)

2 UNITED STATES GONADOTROPIN RELEASING HORMONE COMPETITION BY MANUFACTURERS

2.1 United States Gonadotropin Releasing Hormone Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Gonadotropin Releasing Hormone Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Gonadotropin Releasing Hormone Average Price by Manufactures (2015 and 2016)
2.4 Gonadotropin Releasing Hormone Market Competitive Situation and Trends
  2.4.1 Gonadotropin Releasing Hormone Market Concentration Rate
  2.4.2 Gonadotropin Releasing Hormone Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES GONADOTROPIN RELEASING HORMONE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Gonadotropin Releasing Hormone Sales and Market Share by Type (2011-2016)
3.2 United States Gonadotropin Releasing Hormone Revenue and Market Share by Type (2011-2016)
3.3 United States Gonadotropin Releasing Hormone Price by Type (2011-2016)
3.4 United States Gonadotropin Releasing Hormone Sales Growth Rate by Type (2011-2016)

4 UNITED STATES GONADOTROPIN RELEASING HORMONE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Gonadotropin Releasing Hormone Sales and Market Share by Application (2011-2016)
4.2 United States Gonadotropin Releasing Hormone Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES GONADOTROPIN RELEASING HORMONE MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Gonadotropin Releasing Hormone Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 AEterna Zentaris, Inc. (Canada)
  5.2.2 Gonadotropin Releasing Hormone Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 AEterna Zentaris, Inc. (Canada) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 AstraZeneca Plc. (UK)
  5.3.2 Gonadotropin Releasing Hormone Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 AstraZeneca Plc. (UK) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Bayer HealthCare Pharmaceuticals, Inc. (USA)
  5.4.2 Gonadotropin Releasing Hormone Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Bayer HealthCare Pharmaceuticals, Inc. (USA) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Eli Lilly and Company (USA)
  5.5.2 Gonadotropin Releasing Hormone Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Eli Lilly and Company (USA) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Meditrina Pharmaceuticals, Inc. (US)
  5.6.2 Gonadotropin Releasing Hormone Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Meditrina Pharmaceuticals, Inc. (US) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Neurocrine Biosciences, Inc. (US)
  5.7.2 Gonadotropin Releasing Hormone Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Neurocrine Biosciences, Inc. (US) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Abbott Laboratories (USA)
  5.8.2 Gonadotropin Releasing Hormone Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Abbott Laboratories (USA) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Repros Therapeutics, Inc. (US)
  5.9.2 Gonadotropin Releasing Hormone Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Repros Therapeutics, Inc. (US) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 GONADOTROPIN RELEASING HORMONE MANUFACTURING COST ANALYSIS

6.1 Gonadotropin Releasing Hormone Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Gonadotropin Releasing Hormone

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Gonadotropin Releasing Hormone Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Gonadotropin Releasing Hormone Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES GONADOTROPIN RELEASING HORMONE MARKET FORECAST (2016-2021)

10.1 United States Gonadotropin Releasing Hormone Sales, Revenue Forecast (2016-2021)
10.2 United States Gonadotropin Releasing Hormone Sales Forecast by Type (2016-2021)
10.3 United States Gonadotropin Releasing Hormone Sales Forecast by Application (2016-2021)
10.4 Gonadotropin Releasing Hormone Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Gonadotropin Releasing Hormone
Table Classification of Gonadotropin Releasing Hormone
Figure United States Sales Market Share of Gonadotropin Releasing Hormone by Type in 2015
Table Application of Gonadotropin Releasing Hormone
Figure United States Sales Market Share of Gonadotropin Releasing Hormone by Application in 2015
Figure United States Gonadotropin Releasing Hormone Sales and Growth Rate (2011-2021)
Figure United States Gonadotropin Releasing Hormone Revenue and Growth Rate (2011-2021)
Table United States Gonadotropin Releasing Hormone Sales of Key Manufacturers (2015 and 2016)
Table United States Gonadotropin Releasing Hormone Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Gonadotropin Releasing Hormone Sales Share by Manufacturers
Figure 2016 Gonadotropin Releasing Hormone Sales Share by Manufacturers
Table United States Gonadotropin Releasing Hormone Revenue by Manufacturers (2015 and 2016)
Table United States Gonadotropin Releasing Hormone Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Gonadotropin Releasing Hormone Revenue Share by Manufacturers
Table 2016 United States Gonadotropin Releasing Hormone Revenue Share by Manufacturers
Table United States Market Gonadotropin Releasing Hormone Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Gonadotropin Releasing Hormone Average Price of Key Manufacturers in 2015
Figure Gonadotropin Releasing Hormone Market Share of Top 3 Manufacturers
Figure Gonadotropin Releasing Hormone Market Share of Top 5 Manufacturers
Table United States Gonadotropin Releasing Hormone Sales by Type (2011-2016)
Table United States Gonadotropin Releasing Hormone Sales Share by Type (2011-2016)
Figure United States Gonadotropin Releasing Hormone Sales Market Share by Type in 2015
Table United States Gonadotropin Releasing Hormone Revenue and Market Share by Type (2011-2016)
Table United States Gonadotropin Releasing Hormone Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Gonadotropin Releasing Hormone by Type (2011-2016)
Table United States Gonadotropin Releasing Hormone Price by Type (2011-2016)
Figure United States Gonadotropin Releasing Hormone Sales Growth Rate by Type (2011-2016)
Table United States Gonadotropin Releasing Hormone Sales by Application (2011-2016)
Table United States Gonadotropin Releasing Hormone Sales Market Share by Application (2011-2016)
Figure United States Gonadotropin Releasing Hormone Sales Market Share by Application in 2015
Table United States Gonadotropin Releasing Hormone Sales Growth Rate by Application (2011-2016)
Figure United States Gonadotropin Releasing Hormone Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Gonadotropin Releasing Hormone Sales Market Share (2011-2016)
Table AEterna Zentaris, Inc. (Canada) Basic Information List
Table AEterna Zentaris, Inc. (Canada) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Table AEterna Zentaris, Inc. (Canada) Gonadotropin Releasing Hormone Sales Market Share (2011-2016)
Table AstraZeneca Plc. (UK) Basic Information List
Table AstraZeneca Plc. (UK) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Plc. (UK) Gonadotropin Releasing Hormone Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Basic Information List
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Gonadotropin Releasing Hormone Sales Market Share (2011-2016)
Table Eli Lilly and Company (USA) Basic Information List
Table Eli Lilly and Company (USA) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (USA) Gonadotropin Releasing Hormone Sales Market Share (2011-2016)
Table Meditrina Pharmaceuticals, Inc. (US) Basic Information List
Table Meditrina Pharmaceuticals, Inc. (US) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Table Meditrina Pharmaceuticals, Inc. (US) Gonadotropin Releasing Hormone Sales Market Share (2011-2016)
Table Neurocrine Biosciences, Inc. (US) Basic Information List
Table Neurocrine Biosciences, Inc. (US) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neurocrine Biosciences, Inc. (US) Gonadotropin Releasing Hormone Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Gonadotropin Releasing Hormone Sales Market Share (2011-2016)
Table Repros Therapeutics, Inc. (US) Basic Information List
Table Repros Therapeutics, Inc. (US) Gonadotropin Releasing Hormone Sales, Revenue, Price and Gross Margin (2011-2016)
Table Repros Therapeutics, Inc. (US) Gonadotropin Releasing Hormone Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gonadotropin Releasing Hormone
Figure Manufacturing Process Analysis of Gonadotropin Releasing Hormone
Figure Gonadotropin Releasing Hormone Industrial Chain Analysis
Table Raw Materials Sources of Gonadotropin Releasing Hormone Major Manufacturers in 2015
Table Major Buyers of Gonadotropin Releasing Hormone
Table Distributors/Traders List
Figure United States Gonadotropin Releasing Hormone Production and Growth Rate Forecast (2016-2021)
Figure United States Gonadotropin Releasing Hormone Revenue and Growth Rate Forecast (2016-2021)
Table United States Gonadotropin Releasing Hormone Production Forecast by Type (2016-2021)
Table United States Gonadotropin Releasing Hormone Consumption Forecast by Application (2016-2021)